UK markets closed

PharmaCyte Biotech, Inc. (PMCB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.1000+0.0200 (+0.96%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
30/04/2023
30/04/2022
30/04/2021
Assets
Current assets
Cash
Cash and cash equivalents
68,040
85,401
2,202
Total cash
68,040
85,401
2,202
Total current assets
68,148
85,495
2,275
Non-current assets
Equity and other investments
1,572
1,572
1,572
Intangible assets
3,549
3,549
3,549
Other long-term assets
7.688
7.688
7.372
Total non-current assets
5,129
5,129
5,129
Total assets
73,277
90,624
7,404
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
128.281
205.361
172.261
Accrued liabilities
458.3
499.01
552.517
Other current liabilities
-
-0.001
-
Total current liabilities
586.581
704.37
724.778
Non-current liabilities
Total non-current liabilities
0
0
0
Total liabilities
586.581
704.37
724.778
Stockholders' equity
Common stock
2.16
2.072
0.159
Retained earnings
-115,959
-111,649
-107,409
Accumulated other comprehensive income
-23.003
-15.757
-20.382
Total stockholders' equity
72,690
89,920
6,679
Total liabilities and stockholders' equity
73,277
90,624
7,404